[HTML][HTML] Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
…, C Zerbini, R Bailey, KA Swanson… - New England journal …, 2020 - Mass Medical Soc
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …
[HTML][HTML] Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months
…, C Zerbini, R Bailey, KA Swanson… - … England Journal of …, 2021 - Mass Medical Soc
Background BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine
encoding a prefusion-stabilized, membrane-anchored severe acute respiratory syndrome …
encoding a prefusion-stabilized, membrane-anchored severe acute respiratory syndrome …
[HTML][HTML] COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
…, PY Shi, C Fontes-Garfias, JL Perez, KA Swanson… - Nature, 2020 - nature.com
An effective vaccine is needed to halt the spread of the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) pandemic. Recently, we reported safety, tolerability and …
coronavirus-2 (SARS-CoV-2) pandemic. Recently, we reported safety, tolerability and …
[HTML][HTML] Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates
…, MJ Mulligan, R Bailey, KA Swanson… - … England Journal of …, 2020 - Mass Medical Soc
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections
and the resulting disease, coronavirus disease 2019 (Covid-19), have spread to millions of …
and the resulting disease, coronavirus disease 2019 (Covid-19), have spread to millions of …
[HTML][HTML] Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age
…, E Lagkadinou, KA Swanson… - … England Journal of …, 2022 - Mass Medical Soc
Background Safe, effective vaccines against coronavirus disease 2019 (Covid-19) are urgently
needed in children younger than 12 years of age. Methods A phase 1, dose-finding study …
needed in children younger than 12 years of age. Methods A phase 1, dose-finding study …
[HTML][HTML] Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants
…, KU Jansen, AS Anderson, KA Swanson… - … England Journal of …, 2023 - Mass Medical Soc
Background Whether vaccination during pregnancy could reduce the burden of respiratory
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …
[HTML][HTML] Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents
…, S Senders, R Bailey, KA Swanson… - … England Journal of …, 2021 - Mass Medical Soc
Background Until very recently, vaccines against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) had not been authorized for emergency use in persons younger than …
2 (SARS-CoV-2) had not been authorized for emergency use in persons younger than …
[HTML][HTML] Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults
…, AS Anderson, KU Jansen, KA Swanson… - … England Journal of …, 2023 - Mass Medical Soc
Background Respiratory syncytial virus (RSV) infection causes considerable illness in older
adults. The efficacy and safety of an investigational bivalent RSV prefusion F protein–based (…
adults. The efficacy and safety of an investigational bivalent RSV prefusion F protein–based (…
[HTML][HTML] Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
…, S Lockhart, K Neuzil, V Raabe, R Bailey, KA Swanson… - Nature, 2020 - nature.com
In March 2020, the World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19),
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
…, S Shpyro, A Finlayson, H Cai, Q Yang, KA Swanson… - Science, 2022 - science.org
The globally circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variant of concern Omicron (B.1.1.529) has a large number of mutations, especially in the spike …
variant of concern Omicron (B.1.1.529) has a large number of mutations, especially in the spike …